Basic & Translational Research

Two research teams have developed very different ways of tackling retinitis pigmentosa, but both hold great promise

Object motion detector cell function relies on a unique interneuron and a special ‘sidekick’ recognition protein

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.

A novel signaling pathway that leads to choroidal neovascularization has been identified – with obvious therapeutic potential

Gut microbes may be responsible for activating the T-cells that cause autoimmune uveitis

Can amniotic stem cells suppress pathologic retinal neovascularization?

Across medicine, far fewer clinical trials report positive results these days. Whether the demise of sharp scientific practices or the lack of low-hanging fruit – does it apply to ophthalmology?

Looking at vitreous samples allows us to determine which proteins are involved in the disease process, and to what degree

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.